The Senate HELP Committee held a hearing to address the high cost of semaglutide drugs, finding that many patients cannot ...

The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...

FTC files lawsuit against top PBMs and GPOs for alleged anticompetitive practices in inflating insulin prices. Learn about the allegations and responses.

In a landmark move, the FTC filed a lawsuit targeting the “Big Three” PBMs: CVS Health’s Caremark Rx, Cigna’s Express Scripts (ESI), and UnitedHealth Group’s OptumRx. The suit also includes their ...

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...

Unsurprisingly, CVS Health, Cigna, and UnitedHealth Group stocks fell last week after the FTC lawsuit announcement. But are ...

This week's healthcare newsletter looks at the prospect for prior authorization reform for prescription drugs and a major FTC ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Plus: What the Secret Service says it got wrong in the July shooting of former President Donald Trump. | FTC sues pharmacy ...

The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices. The FCC says CVS Health's Caremark Rx, Cigna's Express Scripts and United Health Group's OptumRx ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...